SI
|
Brand
|
Company
|
Value
(Cr)
|
GRW
|
Cont% On Total Sale
|
1
|
SECLO
|
Square
|
134
|
37
|
1.67
|
2
|
LOSECTIL
|
SK+F
|
93
|
33
|
1.15
|
3
|
PANTONIX
|
Incepta
|
72
|
37
|
0.90
|
4
|
NAPA
|
Beximco
|
69
|
30
|
0.86
|
5
|
NEOTACK
|
Square
|
68
|
25
|
0.84
|
6
|
CEF-3
|
Square
|
65
|
33
|
0.80
|
7
|
NEOCEPTIN R
|
Beximco
|
64
|
-2.4
|
0.80
|
8
|
MAXPRO
|
Renata
|
56
|
66
|
0.70
|
9
|
ZIMAX
|
Square
|
54
|
23
|
0.67
|
10
|
CIPROCIN
|
Square
|
53
|
13
|
0.66
|
11
|
NAPA EXTRA
|
Beximco
|
44
|
44
|
0.55
|
12
|
XELDRIN
|
ACI
|
43
|
18
|
0.53
|
13
|
VOLTALIN
|
Novartis
|
40
|
46
|
0.50
|
14
|
SERGEL
|
Healtcare
|
40
|
56
|
0.49
|
15
|
FUROCEF
|
Renata
|
34
|
35
|
0.42
|
16
|
LEBAC
|
Square
|
33
|
0.7
|
0.41
|
17
|
CEFTRON
|
Square
|
32
|
-4.1
|
0.40
|
18
|
MIXTARD 30
|
Novo Nor.
|
32
|
36
|
0.39
|
19
|
ROLAC
|
Renata
|
31
|
27
|
0.39
|
20
|
OMEP
|
Aristo
|
31
|
43
|
0.38
|
Description of various medicines, disease profile, drug related study and research.
Wednesday, May 9, 2012
Top 20 Brand of Bangladesh Pharma Market: 2011
Top 20 Generics of Bangladesh Pharma Market: 2011
Rank
|
Generic
|
Market Size (Cr)
|
Grw%
|
Position Change
from last year
|
No. of
Manufacturer
|
1
|
OMEPRAZOLE
|
482
|
26
|
▬
|
98
|
2
|
CEFIXIME
|
276
|
30
|
▲1
|
71
|
3
|
AZITHROMYCIN
|
245
|
20
|
▲1
|
62
|
4
|
RANITIDINE
|
245
|
14
|
▼2
|
95
|
5
|
PARACETAMOL
|
211
|
24
|
▲1
|
109
|
6
|
ESOMEPRAZOLE
|
211
|
67
|
▲4
|
45
|
7
|
CIPROFLOXACIN
|
203
|
9
|
▼2
|
118
|
8
|
CEFUROXIME
|
183
|
34
|
▼1
|
41
|
9
|
INSULIN HU
|
134
|
32
|
▲4
|
6
|
10
|
ZINC
|
134
|
16
|
▲2
|
301
|
11
|
PANTOPRAZOLE
|
133
|
41
|
▲5
|
40
|
12
|
CEFTRIAXONE
|
133
|
2
|
▼4
|
34
|
13
|
AMOXICILLIN
|
129
|
3
|
▼2
|
97
|
14
|
CEFRADINE
|
125
|
-2
|
▼5
|
80
|
15
|
LOSARTAN
|
123
|
33
|
▲2
|
59
|
16
|
AMLODIPINE
|
122
|
26
|
▼1
|
61
|
17
|
INSULIN H. iso
|
114
|
36
|
▲3
|
6
|
18
|
DICLOFENAC
|
112
|
14
|
▼4
|
107
|
19
|
ATORVASTATIN
|
112
|
38
|
▬
|
39
|
20
|
KETOROLAC
|
109
|
26
|
▼2
|
50
|
Subscribe to:
Posts (Atom)